Francesca Damiani Victorelli

Francesca Damiani Victorelli

Auto-generated profile, based on publicly available information

Francesca Damiani Victorelli

Department of Health Sciences & Technology ETH Zurich Zurich 8092 Switzerland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2018 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
RARenata Carolina Alves
Renata Carolina Alves
RFRichard Perosa Fernandes
Richard Perosa Fernandes
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
FVFrancesca Damiani Victorelli
Francesca Damiani Victorelli
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Curcumin, a natural compound extracted from turmeric (Curcuma longa), has been extensively studied because of its various pharmacological properties, such as anti-inflammatory, antioxidant, antibiotic, antiprotozoal, immunomodulatory, anti-proliferative, antitumor, and anticarcinogenic effects. However, low solubility in aqueous media has limited its therapeutic applications. To overcome these bioavailability issues, the use of drug delivery systems providing localized or targeted delivery of this drug may represent a more viable therapeutic option. Several drug delivery systems have been shown to significantly enhance the therapeutic efficacy of curcumin. Additionally, a wide variety of analytical methods are available for the qualitative and quantitative analysis of curcumin in different matrices, including plant extracts, biological fluids, and drug delivery systems. There are a variety of methodologies to quantify curcumin, but chromatographic and spectroscopic techniques are the ones most commonly used. Thus, in this review, we evaluate the biological properties of curcumin, as well as its nanotechnology-based delivery systems and methods of analysis.

1 February 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
FVFrancesca Damiani Victorelli
Francesca Damiani Victorelli
CRCamila Fernanda Rodero
Camila Fernanda Rodero
VLViviane Lutz‐Bueno
Viviane Lutz‐Bueno
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
RMRaffaele Mezzenga
Raffaele Mezzenga
Despite their distinctive secondary structure based on cross β‐strands, amyloid fibrils (AF) are stable fibrous protein aggregates with features similar to collagen, one of the main components of the extracellular matrix, and thus constitute a potential scaffold for enhancing cell adhesion for topical applications. Here, the contribution of AF to skin bio‐adhesivity aiming toward topical treatments is investigated. Liquid crystalline mesophase (LCM) based on phytantriol is formulated, with the aqueous phase containing either water or a solution of 4 wt% amyloid fibrils. Then resveratrol is added as a model anti‐inflammatory molecule. The developed LCM presents a double gyroid Ia3d mesophase. The incorporation of AF into the LCM increases its bio‐adhesive properties. In vitro release and ex vivo permeation and retention confirm the controlled release property of the system, and that resveratrol is retained in epidermis and dermis, but is also permeated through the skin. All formulations are biocompatible with L929 cells. The in vivo assay confirms that systems with AF lead to a higher anti‐inflammatory effect of resveratrol. These results confirm the hypothesis that the incorporation of AF in the LCM increases the bio‐adhesiveness and efficiency of the system for topical treatment, and consequently, the therapeutical action of the encapsulated drug.

1 March 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PSPatricia Bento Da Silva
Patricia Bento Da Silva
VAVictor Hugo Sousa Araújo
Victor Hugo Sousa Araújo
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
MSMariana Cristina Solcia
Mariana Cristina Solcia
CRCamila Maringolo Ribeiro
Camila Maringolo Ribeiro
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
The indiscriminate use of antibiotics has facilitated the growing resistance of bacteria, and this has become a serious public health problem worldwide. Several microorganisms are still resistant to multiple antibiotics and are particularly dangerous in the hospital and nursing home environment, and to patients whose care requires devices, such as ventilators and intravenous catheters. A list of twelve pathogenic genera, which especially included bacteria that were not affected by different antibiotics, was released by the World Health Organization (WHO) in 2017, and the research and development of new antibiotics against these genera has been considered a priority. The nanotechnology is a tool that offers an effective platform for altering the physicalchemical properties of different materials, thereby enabling the development of several biomedical applications. Owing to their large surface area and high reactivity, metallic particles on the nanometric scale have remarkable physical, chemical, and biological properties. Nanoparticles with sizes between 1 and 100 nm have several applications, mainly as new antimicrobial agents for the control of microorganisms. In the present review, more than 200 reports of various metallic nanoparticles, especially those containing copper, gold, platinum, silver, titanium, and zinc were analyzed with regard to their anti-bacterial activity. However, of these 200 studies, only 42 reported about trials conducted against the resistant bacteria considered a priority by the WHO. All studies are in the initial stage, and none are in the clinical phase of research.

7 September 2021 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
MFMariza Aires Fernandes
Mariza Aires Fernandes
JEJosimar Eloy
Josimar Eloy
FVFrancesca Damiani Victorelli
Francesca Damiani Victorelli
PFPaula Scanavez Ferreira
Paula Scanavez Ferreira
APAndressa Maria Pironi
Andressa Maria Pironi
Marlus ChorilliMarlus Chorilli
Marlus Chorilli